Related Experiment Video
Updated: Feb 19, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
A Call to Arms: Quest for a Cryptococcal Vaccine
Marley C Caballero Van Dyke1, Floyd L Wormley1
1Department of Biology, The University of Texas at San Antonio, San Antonio, TX, USA; The South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX, USA.
No licensed vaccines exist for cryptococcosis, a major global health threat, especially for AIDS patients. Continued research investment is crucial for developing effective vaccines to prevent this serious fungal infection.
Area of Science:
- Mycology
- Immunology
- Vaccinology
Background:
- Cryptococcosis is a life-threatening fungal infection with high morbidity and mortality worldwide.
- Immunocompromised individuals, particularly those with Acquired Immunodeficiency Syndrome (AIDS), are disproportionately affected.
- Currently, no approved vaccines are available for the prevention or treatment of cryptococcosis.
Purpose of the Study:
- To provide a rationale for sustained investment in Cryptococcus vaccine research.
- To identify and discuss potential challenges in developing a cryptococcal vaccine.
- To review the current progress in the scientific literature regarding vaccine development for cryptococcosis.
Main Methods:
- Literature review of existing research on Cryptococcus and vaccine development.
- Analysis of the current landscape of vaccine research and development.
- Identification of key challenges and future directions in the field.
Main Results:
- Significant global burden of cryptococcosis necessitates urgent vaccine solutions.
- Development of a cryptococcal vaccine faces immunological and logistical hurdles.
- Promising research avenues are emerging, requiring continued scientific focus.
Conclusions:
- Continued investment in Cryptococcus vaccine research is strongly supported by the disease's impact.
- Overcoming specific challenges is essential for successful vaccine development.
- The review highlights the ongoing progress and future potential for a preventive cryptococcosis vaccine.
Related Concept Videos
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

